Agilon Health Inc is a healthcare company that focuses on transforming the delivery of primary care through its innovative platform designed for value-based care. By partnering with primary care physicians, Agilon enhances their capabilities and support systems, allowing them to improve patient care and outcomes while managing costs more effectively. The company leverages data analytics and technology to enable a seamless integration of services, facilitating better health management for patients and creating a sustainable model for healthcare providers. Through its collaborations, Agilon is dedicated to creating a more efficient healthcare experience that prioritizes wellness and preventive care. Read More
Healthcare services company Agilon Health (NYSE:AGL) missed Wall Street’s revenue expectations in Q2 CY2025, with sales falling 5.9% year on year to $1.39 billion. Its non-GAAP loss of $0.25 per share was significantly below analysts’ consensus estimates.
A number of stocks traded in opposite directions in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed inflation rose by a modest 0.2% in July and 2.7% over the last year. This cooler-than-expected data prompted a significant market rally, with the S&P 500, Dow, and Nasdaq all climbing as investors grew more optimistic. The prevailing view is that easing inflation gives the central bank room to lower interest rates. Lower rates typically reduce borrowing costs for businesses and make stocks more attractive relative to bonds, contributing to widespread gains across sectors like healthcare.
Rock-bottom prices don't always mean rock-bottom businesses.
The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value trap?
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options
NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. (“agilon” or the “Company”) (NYSE: AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential.
However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session.
Shares of healthcare services company Agilon Health (NYSE:AGL) fell 51.6% in the morning session after the company reported dismal second-quarter financial results, announced the departure of its CEO, and withdrew its full-year guidance.
Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
The DJS Law Group announces that it is investigating claims on behalf of investors of agilon health, inc. (“Agilon” or “the Company”) (NYSE: AGL) for violations of the securities laws.
